Search research articles
Contact Us
Filters
Showing results (41-50 of 99) with videos related to
Page
of 10
Sort By:
Haematologica
|
August 31, 2019
The prevalence of extramedullary acute myeloid leukemia detected by <sup>18</sup>FDG-PET/CT: final results from the prospective PETAML trial
Friedrich Stölzel, Tors Lüer, Steffen Löck, et al.
British Journal of Haematology
|
March 13, 2018
Anti-CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial
Johannes Schetelig, Cornelia S Link, Gernot Stuhler, et al.
Hemasphere
|
September 24, 2024
Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real-world cohort of patients with lower-risk MDS
Paolo Mazzeo, Christina Ganster, John Wiedenhöft, et al.
Nano Letters
|
August 14, 2020
Nanocytometer for smart analysis of peripheral blood and acute myeloid leukemia: a pilot study
Julian Schütt, Diana Isabel Sandoval Bojorquez, Elisabetta Avitabile, et al.
Cancer Management and Research
|
February 25, 2022
Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse
Katja Sockel, Friedrich Stölzel, Franziska Hönl, et al.
NPJ Digital Medicine
|
March 22, 2025
Synthetic bone marrow images augment real samples in developing acute myeloid leukemia microscopy classification models
Jan-Niklas Eckardt, Ishan Srivastava, Zizhe Wang, et al.
Hemasphere
|
March 18, 2025
Mitigation of atrial fibrillation-related complications with antithrombotic and cytoreductive therapy in patients with Myeloproliferative Neoplasms: Implications from the GSG-MPN bioregistry
Hyunyee Rosa Cho, Susanne Isfort, Kim Kricheldorf, et al.
Annals of Hematology
|
September 6, 2025
Comparison of prognostication by IPSS-M, IPSS-R and AIPSS-MDS in the context of limited availability of molecular data in daily clinical practice
Felicitas Schulz, Carolin Kellersmann, Beate Betz, et al.
Leukemia
|
December 5, 2019
Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents
Anne Sophie Kubasch, Freya Schulze, Aristoteles Giagounidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 23, 2022
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study
Uwe Platzbecker, Katharina S Götze, Philipp Kiewe, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 99) with videos related to
Sort By:
Page
of 10
Haematologica
|
August 31, 2019
The prevalence of extramedullary acute myeloid leukemia detected by <sup>18</sup>FDG-PET/CT: final results from the prospective PETAML trial
Friedrich Stölzel, Tors Lüer, Steffen Löck, et al.
British Journal of Haematology
|
March 13, 2018
Anti-CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial
Johannes Schetelig, Cornelia S Link, Gernot Stuhler, et al.
Hemasphere
|
September 24, 2024
Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real-world cohort of patients with lower-risk MDS
Paolo Mazzeo, Christina Ganster, John Wiedenhöft, et al.
Nano Letters
|
August 14, 2020
Nanocytometer for smart analysis of peripheral blood and acute myeloid leukemia: a pilot study
Julian Schütt, Diana Isabel Sandoval Bojorquez, Elisabetta Avitabile, et al.
Cancer Management and Research
|
February 25, 2022
Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse
Katja Sockel, Friedrich Stölzel, Franziska Hönl, et al.
NPJ Digital Medicine
|
March 22, 2025
Synthetic bone marrow images augment real samples in developing acute myeloid leukemia microscopy classification models
Jan-Niklas Eckardt, Ishan Srivastava, Zizhe Wang, et al.
Hemasphere
|
March 18, 2025
Mitigation of atrial fibrillation-related complications with antithrombotic and cytoreductive therapy in patients with Myeloproliferative Neoplasms: Implications from the GSG-MPN bioregistry
Hyunyee Rosa Cho, Susanne Isfort, Kim Kricheldorf, et al.
Annals of Hematology
|
September 6, 2025
Comparison of prognostication by IPSS-M, IPSS-R and AIPSS-MDS in the context of limited availability of molecular data in daily clinical practice
Felicitas Schulz, Carolin Kellersmann, Beate Betz, et al.
Leukemia
|
December 5, 2019
Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents
Anne Sophie Kubasch, Freya Schulze, Aristoteles Giagounidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 23, 2022
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study
Uwe Platzbecker, Katharina S Götze, Philipp Kiewe, et al.
Page
of 10